Outsourced Services > Miscellaneous

Username

Password

Home

Forgotten Password?

Site Map

Advertising

THE DEFINITIVE ARTICLE SEARCH FOR THE GLOBAL PHARMACEUTICALS MARKET

Search:

Advanced Search

This channel: Outsourced Services > Miscellaneous

More in detail

Company	:	Gruenenthal GmbH
Date Published	:	01/10/2007

Articles in
Miscellaneous:

Select to view sub-categories of this category

Subject	Contributor	Date Published
Pfizer withdraws application to switch Viagra to non-prescription status in Europe	Pfizer	20/11/2008
BASi opens new office in Europe to better serve pharmaceutical and biotech companies	BASi	12/11/2008
Fuld & Co: biotech sector spends less on intelligence programmes than telecomms	Fuld & Co	12/11/2008
Daiichi Sankyo Europe GMBH announce SEVIKAR(R), a new fixed dose combination treatment for essential hypertension	Daiichi Sankyo, Inc.	12/11/2008
LCP- AtorFen Phase II data to be presented at the American Heart Association's 2008 scientific sessions in new Orleans, La, on November 11	Lifecycle Pharma A/S	11/11/2008
Oncolytics Biotech Inc. collaborators present positive combination REOLYSIN(R) and docetaxel results at iSBTC annual meeting	Oncolytics Biotech Inc.	03/11/2008
Thermo Fisher Scientific Announces Collaboration with Queen’s University Belfast for the Analysis of Peptides within Amphibian Venoms	Thermo Fisher Scientific Inc.	29/10/2008
Laureate Pharma announces agreement with Tolera Therapeutics, Inc.	Laureate Pharma, Inc.	28/10/2008
Biotage Introduces a New Synthesis and Purification Catalog	Biotage	28/10/2008
96-week data from Castle Study continue to show similar efficacy between once-daily REYATAZ(R) (atazanavir sulfate)/ritonavir and twice-daily lopinavir/ritonavir in previously untreated HIV-1 infected adult patients	Bristol-Myers Squibb	26/10/2008
New data confirm consistent efficacy and favourable safety profile of Resolor(R) (Prucalopride) for patients with severe chronic constipation	Movetis NV	22/10/2008
Ironwood presents positive Phase 2b study results for linaclotide in patients with irritable bowel syndrome with constipation	Ironwood Pharmaceuticals, Inc.	21/10/2008
Vertex announces positive 28-day results for VX-770, an oral investigational agent that targets a defective protein responsible for cystic fibrosis	Vertex Pharmaceuticals	20/10/2008
TYSABRI(R) demonstrates sustained improvement in functional outcomes in multiple sclerosis patients according to new post-hoc analysis	Biogen Idec	19/09/2008
Laureate Pharma to add more manufacturing capacity	Laureate Pharma, Inc.	18/09/2008
New Xcelohood(TM) containment hood for safer micro-filling of potent compounds	Capsugel	17/09/2008
What is the potential of the wound care market in Eastern Europe?	Frost & Sullivan	17/09/2008
More people with Down syndrome are being born, achieving more and living longer than ever before	Down Syndrome Education International	16/09/2008
What is the future for laboratory information systems?	Frost & Sullivan	10/09/2008
DSM Pharmaceutical products announces the appointment of That's Nice LLC as agency of record for marketing	DSM	10/09/2008

First

1 to 20 of 193

Last

Terms and Conditions Privacy Policy